Receipts were probably better than I thought, although we are probably now moving into the 2 slower quarters historically. Potentially additional sales via Soft-Tex can however boost these next 2 coming quarters as it doesn't look like the FR sock will in the short term ("The Company is in initial stages of working with new and existing customers as to how they can utilize this technology") or the relationship with ICL.
The funding under the CARES program helped lower cash outflows otherwise ending cash balances would be worse. Its a loan but looks like it doesn't have to be paid back.
PineBelt and the military testing has resumed but really I have no idea of how this is going and the article Susieq posted yesterday hints at possible revenue still a year away (probably if all goes well) but imo potentially longer.
Company still has potential, but revenue isn't growing fast enough - nor are their projects ... yes Covid has impacted and things do take time - but AJX has to be take care with its cash management so time isn't really on its side.
- Forums
- ASX - By Stock
- AJX
- Ann: Quarterly Activity Report and Appendix 4C
Ann: Quarterly Activity Report and Appendix 4C, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.001(4.55%) |
Mkt cap ! $17.96M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $575 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 136750 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2629961 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 136750 | 0.011 |
5 | 4986365 | 0.010 |
3 | 511210 | 0.009 |
2 | 182600 | 0.008 |
1 | 200000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2629961 | 3 |
0.013 | 1987914 | 4 |
0.014 | 134311 | 1 |
0.015 | 36316 | 2 |
0.017 | 15000 | 1 |
Last trade - 15.18pm 15/07/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online